Cargando…

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus

BACKGROUND: The “gold standard” for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV). This testing is time and resource intensive, and development of alternative methods is a priori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dey, Ayan, Molodecky, Natalie A., Verma, Harish, Sharma, Prashant, Yang, Jae Seung, Saletti, Giulietta, Ahmad, Mohammad, Bahl, Sunil K., Wierzba, Thomas F., Nandy, Ranjan K., Deshpande, Jagadish M., Sutter, Roland W., Czerkinsky, Cecil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701219/ https://www.ncbi.nlm.nih.gov/pubmed/26730586 http://dx.doi.org/10.1371/journal.pone.0146010

Ejemplares similares

Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
por: Verma, Harish, et al.
Publicado: (2018)

Survey of poliovirus antibodies in Borno and Yobe States, North-Eastern Nigeria
por: Gofama, Mustapha Modu, et al.
Publicado: (2017)

Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
por: Ahmad, Mohammad, et al.
Publicado: (2021)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Comparison of IPV to tOPV week 39 boost of primary OPV vaccination in Indian infants: an open labelled randomized controlled trial
por: Kanungo, Suman, et al.
Publicado: (2017)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

Mucosal immunity to poliovirus
por: Connor, Ruth I., et al.
Publicado: (2021)

Mucosal Vaccines: An Overview
por: Boyaka, Prosper N., et al.
Publicado: (2005)

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria
por: Iliyasu, Zubairu, et al.
Publicado: (2016)

Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
por: Sharma, Deepa K., et al.
Publicado: (2015)

Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian Children
por: Tagbo, Beckie N, et al.
Publicado: (2020)

Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
por: Resik, Sonia, et al.
Publicado: (2015)

Antibody secreting B cells and plasma antibody response to rotavirus vaccination in infants from Kolkata India
por: Sinha, Anuradha, et al.
Publicado: (2018)

Real-time reverse transcription-polymerase chain reaction assays for identification of wild poliovirus 1 & 3
por: Sharma, Deepa K., et al.
Publicado: (2015)

Assessment of poliovirus antibody seroprevalence in high risk areas for vaccine derived poliovirus transmission in Madagascar
por: Razafindratsimandresy, Richter, et al.
Publicado: (2018)

Estimating the Extent of Vaccine-Derived Poliovirus Infection
por: Wringe, Alison, et al.
Publicado: (2008)

Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic()
por: Molodecky, Natalia A, et al.
Publicado: (2023)

Enteric vaccines for the developing world: challenges and prospects
por: Czerkinsky, Cecil
Publicado: (2011)

Assay for identification of heterozygous single-nucleotide polymorphism (Ala67Thr) in human poliovirus receptor gene
por: Nandi, Shyam Sundar, et al.
Publicado: (2016)

Differential induction of Toll-like receptors & type 1 interferons by Sabin attenuated & wild type 1 polioviruses in human neuronal cells
por: Mohanty, Madhu C., et al.
Publicado: (2013)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2017)

One Full or Two Fractional Doses of Inactivated Poliovirus Vaccine for Catch-up Vaccination in Older Infants: A Randomized Clinical Trial in Bangladesh( )
por: Aziz, Asma B, et al.
Publicado: (2022)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

The Switch From Trivalent to Bivalent Oral Poliovirus Vaccine in the South-East Asia Region
por: Bahl, Sunil, et al.
Publicado: (2017)

Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge
por: Hird, Thomas R., et al.
Publicado: (2012)

Progress Toward Containment of Poliovirus Type 2 — Worldwide, 2017
por: Previsani, Nicoletta, et al.
Publicado: (2017)

Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique
por: de Deus, Nilsa, et al.
Publicado: (2020)

Progress Toward Poliovirus Containment Implementation — Worldwide, 2017–2018
por: Fournier-Caruana, Jacqueline, et al.
Publicado: (2018)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2014–March 2015
por: Diop, Ousmane M., et al.
Publicado: (2015)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2019)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017
por: Jorba, Jaume, et al.
Publicado: (2017)

Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018
por: Jorba, Jaume, et al.
Publicado: (2018)

Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
por: Shirreff, George, et al.
Publicado: (2017)

Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain
por: Shim, Byoung-Shik, et al.
Publicado: (2012)

Regulatory Aspects of Sabin Type 2 Withdrawal From Trivalent Oral Poliovirus Vaccine: Process and Lessons Learned
por: Decina, Daniela, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9kdat1fn7apqpr67r88arafeoc